These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23747036)

  • 1. The role of T cell immunity in HIV-1 infection.
    Munier CM; Kelleher AD; Kent SJ; De Rose R
    Curr Opin Virol; 2013 Aug; 3(4):438-46. PubMed ID: 23747036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the elite: mechanisms of control in HIV-1 infection.
    O'Connell KA; Bailey JR; Blankson JN
    Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
    Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
    J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells and HIV infection; immunity with viral transmission versus compromised cellular immunity?
    Knight SC
    Immunobiology; 2001 Dec; 204(5):614-21. PubMed ID: 11846226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential vaccination strategy focuses on reactivating latent HIV.
    Patience J
    Expert Rev Anti Infect Ther; 2012 May; 10(5):526. PubMed ID: 22702324
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S; López M; Toro C; Jiménez V; Sempere JM; Soriano V; Benito JM
    Clin Infect Dis; 2007 Jan; 44(1):105-10. PubMed ID: 17143825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys.
    Grossman Z; Meier-Schellersheim M; Paul WE; Picker LJ
    Nat Med; 2006 Mar; 12(3):289-95. PubMed ID: 16520776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation.
    Casula M; Vrisekoop N; Wit FW; de Baar MP; de Ronde A; Miedema F; Reiss P
    J Infect Dis; 2007 Aug; 196(3):371-6. PubMed ID: 17597451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression.
    Dalmau J; Rotger M; Erkizia I; Rauch A; Reche P; Pino M; Esteve A; Palou E; Brander C; Paredes R; Phung P; Clotet B; Telenti A; Martinez-Picado J; Prado JG;
    AIDS; 2014 Jun; 28(9):1261-72. PubMed ID: 24732774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell type-specific HIV-1 activation in effector T cells: implications for latent HIV-1 reservoir establishment.
    van der Sluis RM; van Capel TM; Speijer D; Sanders RW; Berkhout B; de Jong EC; Jeeninga RE; van Montfort T
    AIDS; 2015 Jun; 29(9):1003-14. PubMed ID: 25768834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell dynamics in HIV-1 infection.
    Douek DC; Picker LJ; Koup RA
    Annu Rev Immunol; 2003; 21():265-304. PubMed ID: 12524385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells.
    Lisziewicz J; Gabrilovich DI; Varga G; Xu J; Greenberg PD; Arya SK; Bosch M; Behr JP; Lori F
    J Virol; 2001 Aug; 75(16):7621-8. PubMed ID: 11462034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral and host factors in the pathogenesis of HIV infection.
    Derdeyn CA; Silvestri G
    Curr Opin Immunol; 2005 Aug; 17(4):366-73. PubMed ID: 15955686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions.
    Sadat-Sowti B; Parrot A; Quint L; Mayaud C; Debre P; Autran B
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):972-80. PubMed ID: 7511468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.